Tonix Pharmaceuticals Holding Corp. Company Profile (NASDAQ:TNXP)

About Tonix Pharmaceuticals Holding Corp.

Industry, Sector and Symbol:

Sector: Medical
Industry: Drug Manufacturers - Major
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: TNXP
CUSIP:

Key Metrics:

Previous Close: $0.70
50 Day Moving Average: $1.63
200 Day Moving Average: $2.17
52-Week Range: $0.69 - $7.95
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -0.61
P/E Growth: 0.00
Market Cap: $18.10M
Outstanding Shares: 25,860,000
Beta: 2.61

Profitability:

Return on Equity: -131.74%
Return on Assets: -116.12%

Debt:

Current Ratio: 8.03%
Quick Ratio: 8.03%

Additional Links:

Companies Related to Tonix Pharmaceuticals Holding Corp.:

Consensus Ratings for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (?)

Ratings Breakdown:	3 Hold Ratings
Consensus Rating:	Hold (Score: 2.00)
Consensus Price Target:	$8.67 (1,138.10% upside)

Analysts' Ratings History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Show:

Date	Firm	Action	Rating
9/7/2016	Oppenheimer Holdings Inc.	Downgrade	Outperform -> Market Perform
9/7/2016	Roth Capital	Downgrade	Buy -> Neutral
9/7/2016	Cantor Fitzgerald	Downgrade	Buy -> Hold
6/30/2015	Janney Montgomery Scott	Reiterated Rating	Buy

(Data available from 9/30/2014 forward)

Earnings History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Date	Quarter	Consensus Estimate	Actual EPS	Release Link	Conference Call
11/7/2016
8/8/2016	Q2	($0.55)	($0.50)	View	N/A
5/9/2016	Q1	($0.63)	($0.74)	View	N/A
3/4/2016	Q4	($0.66)	($0.71)	View	N/A
8/10/2015	Q215	($0.65)	($0.73)	View	N/A
5/11/2015	Q115	($0.54)	($0.71)	View	N/A
3/3/2015	Q414	($0.81)	($0.83)	View	N/A
11/10/2014	Q314	($0.69)	($0.71)	View	N/A
8/8/2014	Q214	($0.53)	($0.61)	View	N/A
5/13/2014	Q114	($0.35)	($0.59)	View	N/A
3/31/2014		($0.46)	($0.74)	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Current Year EPS Consensus Estimate: $-1.75 EPS
Next Year EPS Consensus Estimate: $-1.15 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.58)	($0.58)	($0.58)
Q2 2016	3	($0.63)	($0.49)	($0.56)
Q3 2016	3	($0.39)	($0.30)	($0.34)
Q4 2016	3	($0.35)	($0.15)	($0.24)

(Data provided by Zacks Investment Research)

Dividend History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Insider Ownership Percentage: 10.20%
Institutional Ownership Percentage: 33.70%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/13/2016	Ernest Mario	Director	Buy	100,000	$0.79	$79,000.00
6/22/2016	Seth Lederman	CEO	Buy	20,000	$2.08	$41,600.00
6/21/2016	Bradley Saenger	CFO	Buy	2,000	$2.00	$4,000.00
6/21/2016	Bruce Daugherty	Insider	Buy	100,000	$2.00	$200,000.00
6/21/2016	John B Rhodes	Director	Buy	25,000	$2.00	$50,000.00
6/3/2016	Gregory M Sullivan	Insider	Buy	20,000	$2.50	$50,000.00
5/12/2016	Ernest Mario	Director	Buy	31,042	$2.30	$71,396.60
5/11/2016	Ernest Mario	Director	Buy	8,210	$2.24	$18,390.40
3/23/2016	Seth Lederman	CEO	Buy	8,000	$2.44	$19,520.00
3/16/2016	Ernest Mario	Director	Buy	75,000	$2.29	$171,750.00
9/30/2015	Gregory M Sullivan	Insider	Buy	5,000	$5.18	$25,900.00
9/28/2015	Gregory M Sullivan	Insider	Buy	4,694	$5.95	$27,929.30
9/25/2015	Seth Lederman	CEO	Buy	6,000	$6.50	$39,000.00
8/26/2015	Ernest Mario	Director	Buy	10,000	$6.05	$60,500.00
8/25/2015	Ernest Mario	Director	Buy	1,468	$6.40	$9,395.20
8/24/2015	Ernest Mario	Director	Buy	2,532	$6.20	$15,698.40
8/20/2015	Ernest Mario	Director	Buy	6,000	$6.64	$39,840.00
8/17/2015	Ernest Mario	Director	Buy	15,000	$6.93	$103,950.00
7/17/2015	John B Rhodes	Director	Buy	6,000	$7.50	$45,000.00
7/17/2015	Leland Gershell	CFO	Buy	1,000	$7.50	$7,500.00
6/11/2015	Gregory M Sullivan	Insider	Buy	4,500	$8.38	$37,710.00
3/17/2015	Seth Lederman	CEO	Buy	2,000	$7.02	$14,040.00
3/13/2015	Seth Lederman	CEO	Buy	2,000	$7.24	$14,480.00
3/11/2015	Seth Lederman	CEO	Buy	2,000	$6.95	$13,900.00
3/10/2015	Charles E Iv Mather	Director	Buy	1,000	$6.80	$6,800.00
3/9/2015	Seth Lederman	CEO	Buy	2,000	$6.48	$12,960.00
3/6/2015	Ernest Mario	Director	Buy	4,000	$6.57	$26,280.00
3/5/2015	Seth Lederman	CEO	Buy	2,000	$6.27	$12,540.00
2/9/2015	Ernest Mario	Director	Buy	30,000	$5.85	$175,500.00
2/9/2015	Leland Gershell	CFO	Buy	5,000	$5.85	$29,250.00
9/27/2013	Charles E Iv Mather	Director	Buy	1,000	$3.65	$3,650.00

(Data available from 1/1/2013 forward)

Latest Headlines for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Date	Headline
	Tonix Pharmaceuticals to Present at 16th Annual Sachs Biotech in Europe Forum (NASDAQ:TNXP) finance.yahoo.com - September 26 at 10:47 AM
	Reviewing Overselling Stock: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post Registrar (NASDAQ:TNXP) postregistrar.com - September 20 at 4:30 PM
	TONIX PHARMACEUTICALS HOLDING CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) (NASDAQ:TNXP) www.4-traders.com - September 19 at 7:38 PM
	Tonix Pharmaceuticals Holding Corp. (TNXP) – Research Analysts ... - DailyQuint (NASDAQ:TNXP) dailyquint.com - September 19 at 9:31 AM
	TONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:TNXP) biz.yahoo.com - September 19 at 9:31 AM
	Insider Trading Review: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - The Voice Registrar (NASDAQ:TNXP) voiceregistrar.com - September 16 at 7:26 PM
	Stock Perspective: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Company Earnings Watch - Frisco Fastball (NASDAQ:TNXP) friscofastball.com - September 15 at 11:26 AM
	Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP): A Potential ... - Street Register (NASDAQ:TNXP) streetregister.com - September 15 at 11:26 AM
	Analysts Place Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Under the Lens of the Microscope - Post News (NASDAQ:TNXP) www.kentuckypostnews.com - September 12 at 9:40 AM
	Overselling Stock in Limelight: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post Registrar (NASDAQ:TNXP) postregistrar.com - September 10 at 6:49 PM
	Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) & Calpine Corporation (NYSE:CPN) UPDATE ON U.S ... - Money News (NASDAQ:TNXP) www.newsismoney.com - September 9 at 9:27 AM
	Most recent Trading report: Tonix Pharmaceuticals Holding Corp.'s (TNXP) (NASDAQ:TNXP) www.crcconnection.com - September 8 at 11:36 AM
	Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) , DaVita healthCare Partners Inc (NASDAQ:TNXP) magseriesusa.net - September 8 at 11:36 AM
	Tonix Pharmaceuticals To Present At Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:TNXP) www.thestreet.com - September 7 at 7:50 PM
	Tonix Pharmaceuticals Shares Plummet 50% On Phase 3 Trial Failure (NASDAQ:TNXP) www.talkmarkets.com - September 7 at 7:50 PM
	Tonix Pharma shares halve after Phase 3 flop (NASDAQ:TNXP) www.proactiveinvestors.com - September 7 at 7:50 PM
	Shares Trading Lower in Today's Session: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post News (NASDAQ:TNXP) www.kentuckypostnews.com - September 6 at 7:50 PM
	Shares Gapping Lower Before the Open: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post News (NASDAQ:TNXP) www.kentuckypostnews.com - September 6 at 7:50 PM
	Stock Update (NASDAQ:TNXP): Tonix Pharmaceuticals Holding Corp. Reports Topline Results from Phase 3 AFFIRM ... - Smarter Analyst (NASDAQ:TNXP) www.smarteranalyst.com - September 6 at 7:50 PM
	REUTERS AMERICA NEWS PLAN FOR TUESDAY SEPT 6 (NASDAQ:TNXP) finance.yahoo.com - September 6 at 7:50 PM
	TNXP: AFFIRM Study Does Not Meet Primary Endpoint; Company to Focus on Development of TNX-102 SL in PTSD (NASDAQ:TNXP) finance.yahoo.com - September 6 at 7:50 PM
	Why This Major Disappointment May Not Mark the End for Tonix Pharmaceuticals (NASDAQ:TNXP) 247wallst.com - September 6 at 7:50 PM
	Tonix to stop testing drug for fibromyalgia, shares plunge (NASDAQ:TNXP) www.reuters.com - September 6 at 9:26 AM
	Form 8-K Tonix Pharmaceuticals For: Sep 06 (NASDAQ:TNXP) www.streetinsider.com - September 6 at 9:26 AM
	Tonix Pharma's lead product candidate TNX-102 SL flunks late-stage study in fibromyalgia; shares slump 16% premarket (NASDAQ:TNXP) seekingalpha.com - September 6 at 9:26 AM
	Tonix Says AFFIRM Data Didn''t Achieve Primary Efficacy Endpoint; Stock Down (NASDAQ:TNXP) www.nasdaq.com - September 6 at 9:26 AM
	Tonix Pharmaceuticals Reports Topline Results from Phase 3 AFFIRM Study of TNX-102 SL in Fibromyalgia and Provides Corporate Update (NASDAQ:TNXP) www.globenewswire.com - September 6 at 9:26 AM
	Tonix says to stop testing pain disorder drug (NASDAQ:TNXP) finance.yahoo.com - September 6 at 9:26 AM
	Stock Down in Trading Session: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post News (NASDAQ:TNXP) www.kentuckypostnews.com - September 1 at 7:42 PM
	Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Secures FDA Green Light - Scibility Media (NASDAQ:TNXP) scibilitymedia.com - August 31 at 9:54 AM
	Active Runners: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Amgen, Inc. (NASDAQ:AMGN), Flowers ... - NYSE Journal (press release) (NASDAQ:TNXP) stockznews.com - August 30 at 7:38 PM
	Tonix Pharmaceuticals Gains On Update for TNX-102 SL (NASDAQ:TNXP) www.baystreet.ca - August 30 at 11:09 AM
	Tonix Pharma (TNXP) Issues Positive Update from End-of-Phase 2/Pre-Phase 3 FDA Meeting for TNX-102 SL in PTSD (NASDAQ:TNXP) www.streetinsider.com - August 30 at 11:09 AM
	Shares Gapping Higher Pre-Market: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Post News (NASDAQ:TNXP) www.kentuckypostnews.com - August 29 at 7:44 PM
	Tonix Pharmaceuticals Holding Corp (TNXP) Stock Jumps as FDA Approves Phase 3 Trial for PTSD - Bidness ETC (NASDAQ:TNXP) www.bidnessetc.com - August 29 at 7:44 PM
	Tonix Pharma up 16% premarket on advancement on TNX-102 SL in PTSD (NASDAQ:TNXP) seekingalpha.com - August 29 at 9:47 AM
	TONIX PHARMACEUTICALS HOLDING CORP. : Other Events, Financial Statements and Exhibits (form 8-K) (NASDAQ:TNXP) www.4-traders.com - August 29 at 9:47 AM
	Tonix Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for TNX-102 SL in Post-Traumatic Stress Disorder (NASDAQ:TNXP) globenewswire.com - August 29 at 9:47 AM
	New Market Research Report: Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial and Strategic SWOT Analysis Review (NASDAQ:TNXP) www.live-pr.com - August 25 at 8:06 PM
	Stocks to Watch: U.S. Auto Parts Network, Inc.(NASDAQ:PRTS), Tonix Pharmaceuticals Holding Corp.(NASDAQ:TNXP) - NYSE Journal (press release) (NASDAQ:TNXP) stockznews.com - August 23 at 7:59 PM
	TNXP: Topline Results From AFFIRM Study in Fibromyalgia in September 2016 (NASDAQ:TNXP) finance.yahoo.com - August 23 at 7:59 PM
	What Does the Consensus Have to Say About Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Shares? - Post News (NASDAQ:TNXP) www.kentuckypostnews.com - August 22 at 9:44 AM
	Will Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Hit $12 Price Target? - Investor Newswire (NASDAQ:TNXP) www.investornewswire.com - August 22 at 9:44 AM
	Early Session Advancers: Ocular Therapeutix (NASDAQ:OCUL), Tonix Pharmaceuticals Holding (NASDAQ:TNXP ... - KC Register (NASDAQ:TNXP) www.kcregister.com - August 15 at 8:12 PM
	Tonix Pharmaceuticals Presents Poster on the Development of TNX-102 SL for Post-Traumatic Stress Disorder (PTSD) at the 2016 Military Health System Research Symposium (NASDAQ:TNXP) finance.yahoo.com - August 15 at 9:57 AM
	TONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:TNXP) biz.yahoo.com - August 15 at 9:57 AM
	TONIX PHARMACEUTICALS HOLDING CORP. Financials (NASDAQ:TNXP) finance.yahoo.com - August 13 at 7:23 PM
	TONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD (NASDAQ:TNXP) biz.yahoo.com - August 11 at 11:16 AM
	Here's Why Cantor Reiterates Buy on Tonix Pharmaceuticals Holding Corp. (TNXP) - Smarter Analyst (NASDAQ:TNXP) www.smarteranalyst.com - August 10 at 8:25 PM
	Stocks Attracts Frontline Trades- Inovio Pharmaceuticals (NASDAQ:INO), Tonix Pharmaceuticals (NASDAQ:TNXP) - Seneca Globe (NASDAQ:TNXP) www.senecaglobe.com - August 9 at 8:11 PM